Since COVID-19 was declared a national health emergency in March 2020, a variety of legislative, regulatory and financial changes have been instituted to provide economic stimulus, streamline care and create an infrastructure to help support U.S. citizens and a strained health care system.
Unfortunately, where there are large infusions of public money, criminals and wasteful practices inevitably follow. Our professionals will provide an overview of the domestic response to the pandemic and the fraud that has ensued; demonstrated impacts of fraud on patients, providers and payers; and potential solutions to address the confluence of COVID-19 and bad practices.
This program is part of a weekly webinar series dissecting current and potential areas of fraudulent activity within relief programs and pharmacotherapeutic innovation overseen by numerous government agencies in response to the COVID-19 pandemic. The series will focus on government enforcement risks under various government programs and SEC enforcement, as well as fraud risks facing health care payers and providers as the targets of scammers. For more information or to register for the complete series, please visit the series website.
QUESTIONS? Please contact Mesha Hegna Goodwill or call +1 612 766 7145.